-
Last Nights Noteables, Morning Action August 2
Tuesday, August 2, 2011 - 8:41am | 276AM Action: Nokia (NOK) S&P Downgrades Nokia With Neg Outlook Due To Poor Prospects In Devices & Services Segment Becton Dickinson (BDX) beats by $0.10, beats on revs; raisesFY11 EPS above consensus Sohu.com (SOHU) upgraded to Neutral from Reduce at Nomura - Nomura upgraded Sohu.com based...
-
Piper Jaffray Increases Revenue Estimates Of Hologic For FY11 And FY12
Tuesday, August 2, 2011 - 8:27am | 57According to Piper Jaffray, Hologic (NASDAQ: HOLX), FY11 and FY12 revenues have been revised. Piper Jaffray announced an increase in revenue estimates for FY11 from $1776.5M to $1780.5M and from $1,932.5M to $1,932.8M. PT of $26, EPS estimates, and rating of Overweight have all been maintained....
-
Citi Maintains $26 Price Target On Holigic
Tuesday, August 2, 2011 - 8:21am | 59According to Citi, Hologic (NASDAQ: HOLX) posted a positive F3Q11 with revs above Street and EPS in-line with Street. Citi said that F2011E EPS maintained at $1.26. “We will maintain target price at $26 based on an unchanged 17x P/E on our C2012E EPS of $1.50.” Hologic closed yesterday at $18.05.
-
Piper Jaffray Comments on Cutera Inc
Tuesday, August 2, 2011 - 7:58am | 158Piper Jaffray has published a report on Cutera Inc (NASDAQ: CUTR) reviewing the second quarter at the medical device company. In the report, Piper Jaffray wrote, "CUTR grew revenues 22% and beat ours and consensus estimates reporting $14.9 million. The "above expectations" number is a key...
-
Piper Jaffray Overweight On Baxter International
Tuesday, August 2, 2011 - 7:33am | 159Piper Jaffray is out with a research report on Baxter International (NYSE: BAX) and it has an Overweight rating and a $70 price target on shares. In a note to clients, Piper Jaffray writes, "Adjusted "apples-to-apples" US IVIG distributions accelerated in June, up 18.5% vs. the prior year. The...
-
Goldman Sachs Lowers PT On Hologic To $23
Tuesday, August 2, 2011 - 7:27am | 27Goldman Sachs has lowered the price target on Hologic (NASDAQ: HOLX) from $26 to $23 and maintains its Conviction-List Buy rating.
-
Pier Jaffray Comments on Earnings at Volcano Corporation
Tuesday, August 2, 2011 - 7:14am | 147Piper Jaffray has published a report on Volcano Corporation (NASDAQ: VOLC) reviewing earnings and estimates at the medical products company. In the report, Piper Jaffray wrote, "VOLC met our revenue expectations and exceeded our earnings estimates. Revenues were $84.0M (up 14%, 9% Fx adj), while...
-
Morgan Stanley Reiterates Equal-Weight on Hologic
Tuesday, August 2, 2011 - 7:13am | 60Morgan Stanley reiterated its Equal-weight rating on Hologic (NASDAQ: HOLX). At the moment, the rating agency does not have a price target placed on the company's stock. On Monday, HOLX lost 2.8% of its value to finish the day at $18.05. Its shares continued to slide in today's pre-market trading,...
-
UPDATE: Becton Dickinson Reports Upbeat FQ3 Earnings, Raises Forecast
Tuesday, August 2, 2011 - 7:02am | 86Becton, Dickinson and Company (NYSE: BDX) reported upbeat earnings for the fiscal third quarter on Tuesday. BDX reported its quarterly earnings at $343 million, or $1.53 per share, up from $306 million, or $1.29 per share, in the year-ago quarter. Analysts were expecting earnings of $1.43 per...
-
JP Morgan Raises PT on Volcano Corporation to $38
Tuesday, August 2, 2011 - 6:36am | 28JP Morgan has raised the price target on the Volcano Corporation (NASDAQ: VOLC) from $33 to $38 and maintains its Overweight rating.
-
JP Morgan Lowers PT on Hologic To $20
Tuesday, August 2, 2011 - 6:33am | 26JP Morgan has lowered the price target on Hologic (NASDAQ: HOLX) from $24 to $20 and maintains its Overweight rating.
-
Goldman Sachs Discusses Hill-Rom Holdings
Monday, August 1, 2011 - 3:39pm | 122Goldman Sachs is out with a research report on Hill-Rom Holdings, Inc. (NYSE: HRC) and it has a Neutral rating on shares. In a note to clients, Goldman Sachs writes, "Hill-Rom currently generates about 3% of revenue from SNF capital sales, and these products typically are lower-tech and lower-...
-
Options Brief: Varian Medical Systems
Monday, August 1, 2011 - 1:40pm | 79Shares of Varian Medical Systems (NYSE: VAR) are lower on the session by 3.73%, trading at $60.42. Overall call volume is now running at 3.04x the daily average, with 60% of all calls traded being purchases on the offer. 1,557 contracts have traded on the session so far. Varian Medical Systems,...
-
Friday's NASDAQ Top Percentage Gainers: Allied Healthcare, Opexa Therapeutics, ZOLL Medical, Sify Technologies
Monday, August 1, 2011 - 10:59am | 501POINT ROBERTS, August 1, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for July 29, 2011. On Friday, Allied Healthcare International's stock climbed 56%. Allied Healthcare International Inc. (NASDAQ: AHCI...
-
Misonix Announces New Distribution Agreement for Chile
Monday, August 1, 2011 - 10:42am | 53Misonix, Inc. (NASDAQ: MSON) has entered into a new three-year exclusive distribution agreement with Osteotrauma Ltda., based in Concepcion, Chile. Osteotrauma will sell and distribute the SonaStar® Ultrasonic Surgical Aspirator and the BoneScalpel™ Ultrasonic Bone Cutter throughout Chile. The...